Patent · US Active

Synthetic route to anti-viral agents

US10442792B2 · kind B2 · utility

0Cited by

3References

30Claims

0Family size

Assignee

Abb Vie Inc. · US

Inventors

Russell D. Cink · Grayslake, US
Kirill A. Lukin · Vernon Hills, US
Marvin R. Leanna · Grayslake, US
Matthew J. Pelc · Pleasant Prairie, US
Timothy B. Towne · Lindenhurst, US
Dennie S. Welch · Lake Bluff, US
Kenneth M. Engstrom · Mundelein, US
Matthew M. Ravn · Round Lake Beach, US
Richard D. Bishop · Third Lake, US
Gang Zhao · Oceanside, US
Jianzhang Mei · Lake Forest, US
Jeff M. Kallemeyn · Libertyville, US
David R. Hill · Gurnee, US
Michael J. Abrahamson · Chicago, US
Westin H. Morrill · Grayslake, US

Key dates

Filing date	Sep 17, 2018
Grant date	Oct 15, 2019
Priority date	—
Expiry date	Sep 17, 2038

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07C2601/08
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

The invention provides methods of synthesizing a viral protease inhibitor in high yield, without using expensive catalysts or challenging reaction conditions.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.